Search for: "Sanofi Aventis Deutschland GMBH"
Results 1 - 6 of 6
Sorted by Relevance | Sort by Date
24 May 10:58 pm
... , and obtained, a writ of mandamus to move the patent case from ED Texas to ND California. The opposing party, Sanofi-Aventis Deutschland GmbH, was represented by McDonnell Boehnen Hulbert
& Berghoff LLP, of Chicago. The CAFC mentioned the TS Tech case: ... go to trial is lower in the Eastern District - 18.4 months - than in the Northern District - 25.5 months.
Sanofi also points to a 2008 patent litigation study, which found that in the twenty most active patent districts in the country, the ...
9 Jun, 2008 4:50 am
... cases, and a few interesting cases will be selected for periodic monitoring. Lupin Limited et al. v. Sanofi-Aventis Deutschland GMBH et al. 2:08-cv-00258; filed June 5, 2008 in the
Eastern ... non-infringement and invalidity of U.S. Patent No. 7,368,469 ("Use of Inhibitors of the Renin-Angiotensin System in the Prevention of Cardiovascular Events," issued on May
6, 2008), assigned to Sanofi-Aventis and licensed to King Pharmaceuticals, in conjunction with
Lupin's filing of an ANDA to manufacture a...
15 Jul, 2008 4:57 am
... European Patent No. EP 1 230 375, owned by Cancer Research Therapeutics Ltd. of Cambridge, UK and exclusively licensed to Alnylam Pharmaceuticals, Inc. The patent was opposed by
several companies involved in commercializing RNA interference (RNAi), including Sanofi-Aventis
Deutschland GmbH, Sirna Therapeutics, Nucleonics, Inc., Quark Biotech, and Silence Therapeutics AG.
The patent, commonly referred to as the "Glover ...
16 Jan 7:00 am
... Blog) ECJ: Free of charge gifts and 'genuine use': Silberquelle GmbH v Maselli-Strickmode GmbH
(Class 46) (IPKat) Global Global - General Pharmaceutical patent linkage ... Europe ECJ: Free of charge gifts and 'genuine use': Silberquelle GmbH v Maselli-Strickmode GmbH (Class 46) (IPKat) ECJ to consider interpretation of Article 14(3) ... High Court
(Law360) (Discussion of FTC's petition for certiorari - Patently-O) Sanofi-Aventis Deutschland - Sanofi sues Novo Nordisk over safety needle patent (Law360) ...
16 Dec, 2008 11:47 pm
... rarely occurring but serious blood disorders, neutropenia and thrombotic thrombocytopenic purpura, associated with prolonged usage of ticlopidine. Sanofi then synthesized and evaluated several hundred additional thienopyridine derivatives, including a class of compounds having ... in light of the known
racemate, when it was shown that the therapeutic properties of the (+) enantiomer were unexpected. In contrast, in Aventis Pharma
Deutschland GmbH v. Lupin, Ltd. 499 F.3d 1293, 1302 (Fed. Cir. 2007), ...
28 Apr, 2008 11:00 am
... in one proceeding in another proceeding involving a different party, with the exception of one set of documents: Sanofi-Aventis et al v Apotex: (Gowlings), Androgel (Testosterone) - US FTC turns to ... but finds second patent eligible for listing so should proceeds to hearing
on the merits: Nycomed GmbH and Nycomed Canada Inc v Minister of Health and Genpharm Inc: ( ... (Catch Us If You Can!!!), Ferrero fends off
Ferro CTM: Ferrero Deutschland v OHIM, Cornu SA Fontain: (Class 46), File-sharing should not ...
Search on: Blawgs.FM | BlawgSearch Google Co-op |
Blawg.com | Bloglines | Feedster | Google Blog
Search | Technorati | Google | MSN | Yahoo!